Mostrar el registro sencillo del ítem

dc.contributor.advisorOliveros Rodríguez, Henry
dc.contributor.authorCorzzo Perez, Dinia Rosa
dc.date.accessioned2012-03-13T15:59:27Z
dc.date.available2012-03-13T15:59:27Z
dc.date.created2011
dc.date.issued2012-03-13
dc.identifier.citationHendrickx GR, Millard RW, Mc Ritchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56:978-85.
dc.identifier.citationBraunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
dc.identifier.citationFerez SM, Marquez MF, Peña MA,Ocaranza R, Dela Peña E,Eid Lidt G. Daño miocárdico por reperfusión. Rev Esp Cardiol 2004; 57 (supl 1): 9-21
dc.identifier.citationDe Micheli A, Aranda A, Chávez E. Sustratos celulares del síndrome de infarto miocárdico agudo. Arch Inst Cardiol Mex 1995;65:79-88.
dc.identifier.citationJennings RB, Murry CE, Steenberg C Jr, Reimer KA. Development of cell injury in sustained acute ischemia. Circulation 1990;82(3 Suppl):II2-12.
dc.identifier.citationSommers HM, Jennings RB. Experimental acute myocardial infarction: histologic and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery. Lab Invest 1964;13:1491-502.
dc.identifier.citationCain BS, Meldrum D. Meng X, Shames B, Banerjee A, Harken A. Calcium preconditioning in human myocardium. Ann Thorac Surg 1998;65:1065-70.
dc.identifier.citationLucas DT, Sweda LI. Cardiac reperfusion injury: aging, lipid perodixation, and mithocondrial dysfunction. Proc Natl Acad SCI USA 1998;95:510-4.
dc.identifier.citationBasu S, Nozari A, Liu XL, Rubertson S, Wiklund L. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Lett Mar 17:470:1-6.
dc.identifier.citationNayler WG. The role of calcium in the ischemic myocardium. Am J Pathol 1981;102:262-70
dc.identifier.citationLevitsky T, Gurell D, Frishman W. Sodium ion/hydrogen ion exchange inhibition: a new pharmacologic approach to myocardial ischaemia and reperfusion injury. J Clin Pharmacol 1998; 38:10;887-97.
dc.identifier.citationValverde CA, Kornyeyev D, Ferreiro M, Petrosky AD, Mattiazzi A, Escobar AL. Transiet Ca2+ depletion of the sarcoplasmic reticulum at the onset of reperfusion. Cardiovasc Res. 2010 Mar 1;85(4):671-80.
dc.identifier.citationMubagwa K. Sarcoplasmic reticulum function during myocardial ischaemia and reperfusion. Cardiovasc Res 1995;30:166-75.
dc.identifier.citationAuchampach JA, Pieper GM, Cavero I, Gross GJ. Effect of the platetel activating factor antagonist RP 59227 (tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function. Basic Res Cardiol 1998;93:361-71.
dc.identifier.citationForde RC, Fitzgerald DJ. Reactive oxygen species and platelet activation in reperfusion injury. Circulation 1997;95:787-9.
dc.identifier.citationSchulz R, Wamboldt R. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res 1995;30:432-9.
dc.identifier.citationJ.L. McDonough, BSc; R. Labugger, MSc; W. Pickett, PhD; M.Y. Tse, PhD; S. MacKenzie, BSc; S.C. Pang, PhD; D. Atar, MD; G. Ropchan, MD; J.E. Van Eyk, PhD. Cardiac Troponin I Is Modified in the Myocardium of Bypass Patients. Circulation. 2001;103:58-64.
dc.identifier.citationTaegtmeyer H. Metabolic support for the postischaemic heart. Lancet 1995;345:1552-5.
dc.identifier.citationMcDonough JL, Arrell DK, Van Eyk JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res. 1999;84:9 –20.
dc.identifier.citationSolaro RJ. Troponin I, stunning, hypertrophy, and failure of the heart. Circ Res. 1999;84:122–124.
dc.identifier.citationBuja LM, Weerasinghe P. Unresolved issues in myocardial reperfusion injury. Cardiovasc Pathol. 2010 Jan-Feb;19(1):29-35.
dc.identifier.citationLaky D,Parascan L, Candea V. Myocardial stunning. Morphological studies in acute experimental ischemia and intraoperatory myocardial biopsies. Romanian Journal of Morphology and Embryology 2008, 49(2):153–158.
dc.identifier.citationFerrari R. Commentary on myocardial stunning and its clinical relevance. Basic Res Cardiol 1995;90:300-2.
dc.identifier.citationHeusch G. Myocardial stunning: a role for calcium antagonists during ischemia?, Cardiovascular Res, 1992,26(1):14–19.
dc.identifier.citationDzemali O, Bakhtiary F, Dogan S, Wittlinger T, Moritz A, Kleine P. Perioperative Biventricular Pacing Leads to Improvement of Hemodynamics in Patients with Reduced LeftVentricular Function—Interim Results. PACE 2006; 29: 1341–1345
dc.identifier.citationGerald Buckberg, Constantine Athanasuleas, Saleh Saleh. Septal myocardial protection during cardiac surgery for prevention of right ventricular dysfunction. Anadolu Kardiyol Derg 2008; 8: Suppl 2; 108-16
dc.identifier.citationSchroeder E, Marchandise B, Schoevaerdts JC, Kremer R. Paradoxical ventricular septal motion after cardiac surgery. Analysis of M-mode echocardiograms and follow-up in 324 patients. Acta Cardiol 1985; 40: 315-24.
dc.identifier.citation.Reynolds HR, Tunick PA, Grossi EA, Dilmanian H, Colvin SB,Kronzon I. Paradoxical septal motion after cardiac surgery: a review of 3,292 cases. Clin Cardiol 2007; 30: 621-3.
dc.identifier.citationChouraqui P, Rabinowitz B, Livschitz S, Horoszowsky D, Kaplinsky E, Smolinsky A. Effects of antegrade versus combined antegrade/ retrograde cardioplegia on postoperative septal wall motion in patients undergoing open heart surgery. Cardiology 1997; 88: 526-9.
dc.identifier.citationHoffman D, Fernandes S, Frater RW, Sisto D. Myocardial protection in diffuse coronary artery disease. Intermittent retrograde cold-blood cardioplegia at systemic normothermia versus intermittent antegrade cold-blood cardioplegia at moderate systemic hypothermia. Texas Heart Inst J 1993; 20: 83-8.
dc.identifier.citationJ.L. McDonough, BSc; R. Labugger, MSc; W. Pickett, PhD; M.Y. Tse, PhD; S. MacKenzie, BSc; S.C. Pang, PhD; D. Atar, MD; G. Ropchan, MD; J.E. Van Eyk, PhD. Cardiac Troponin I Is Modified in the Myocardium of Bypass Patients. Circulation. 2001;103:58-64.
dc.identifier.citationMiller: Miller’s Anesthesia, 6th ed., Copyright © 2005 Elsevier. 617-678.
dc.identifier.citationDe Opie LG: receptors and signal transduction. En Opie LH (ed.): The heart, Physiology from Cell to Circulation, 4a ed. Filadelfia, Lippincott Raven, 2004, pags. 186-220.
dc.identifier.citationTyler M. Yeates, MD, Joshua M. Zimmerman, MD, Michael K. Cahalan, MD*. Perioperative Echocardiography:Two-Dimensional and Three-Dimensional Applications. Anesthesiology Clin 26 (2008) 419–435.
dc.identifier.citationSmith JS, Cahalan MK, Benefiel DJ, et al. Intraoperative detection of myocardial ischemia in high-risk patients: electrocardiography versus two-dimensional transesophageal echocardiography. Circulation 1985;72:1015–21
dc.identifier.citationRoyster RL. Myocardial dysfunction following cardiopulmonary bypass: recovery patterns, predictors of inotropic need, theoretical concepts of inotropic administration. J Cardiothorac Vasc Anesth. 1993 Aug;7(4 Suppl 2):19-25
dc.identifier.citationDiller GP, Wasan BS, Kyriacou A, Patel N, Casula RP, Athanasiou T, Francis DP, Mayet J. Effect of coronary artery bypass surgery on myocardial function as assessed by tissue Doppler echocardiography. Eur J Cardiothorac Surg. 2008 Nov;34(5):995-9.
dc.identifier.citationButterworth JF 4th, Legault C, Royster RL, Hammon JW Jr. Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth Analg. 1998 Mar;86(3):461-7.
dc.identifier.citationQIU Zhi-bing, CHEN Xin, XU Ming, SHI Kai-hu, JIANG Yin-shuo and XIAO Li-qiong. Is the use of cardiopulmonary bypass for isolated coronary artery bypass an independent predictor of mortality and morbidity in patients with severe left ventricular dysfunction? Chinese Medical Journal 2008; 121(23):2397-2402 2397.
dc.identifier.citationAdrian F. Hernandez, MD,a Shuang Li, MS,a Rachel S. Dokholyan, MPH,a Sean M. O’Brien, PhD,a T. Bruce Ferguson, MD,b and Eric D. Peterson, MD, MPH. Variation in perioperative vasoactive therapy in cardiovascular surgical care: Data from the Society of Thoracic Surgeons. Am Heart J 2009;158:47-52
dc.identifier.citationArthur J. Roberts, MD. Stewart M. Spies, MD, John H. Sanders, MD. John M. Moran, MD. Carolyn J. Wilkinson, MD. Peter R. Lichtenthal, MD. Roger L . White, MD. And Lawrence L. Michaelis, MD. Chicago, Ill. Serial assessment of left ventricular performance following coronary artery bypass grafting. J Thorac Cardiovasc Surg 81:69-84, 1981
dc.identifier.citationGray R. Maddahi J , Berman D. Raymond M, Waxman A, Ganz W, Matloff J, Swan HJC: Scintigrafic and hemodynamic demonstration of transient left ventricular dysfunction immediately after uncomplicated coronary artery bypass grafting. J Thorac Cardiovasc Surg 77: 504-510. 1979 .
dc.identifier.citationD’Ancona G, Baillot R, Poirier B, et al: Determinants of gastrointestinal complications in cardiac surgery. Tex Heart Inst J 30:280-285, 2003.
dc.identifier.citationParr KG, Patel MA, Dekker R, et al: Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth 17:176-181, 2003.
dc.identifier.citationCanver CC, Chanda J: Intraoperative and postoperative risk factors for respiratory failure after coronary bypass. Ann Thorac Surg 75:853-857, 2003
dc.identifier.citationMangano CM, Diamondstone LS, Ramsay JG, et al: Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 128:194-203, 1998
dc.identifier.citationSalis S, Mazzanti V, Merli G, Salvi L, Tedesco C: Cardiopulmonary Bypass Duration Is an Independent Predictor of Morbidity and Mortality After Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia, Vol 22, No 6 (December), 2008: pp 814-822.
dc.identifier.citationPalanzo DA: Perfusion safety: Defining the problem. Perfusion 20:195-203, 2005
dc.identifier.citationBucerius J, Gummert JF, Borger MA, et al: Stroke after cardiac surgery: A risk factor analysis of 16184 consecutive adult patients.AnnThorac Surg 75:472-478, 2003
dc.identifier.citationHogue CW Jr, Murphy SF, Schechtman KB, et al: Risk factors for early or delayed stroke after cardiac surgery. Circulation 100:642-647, 1999
dc.identifier.citationRoques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J. 2003 May;24(9):882-3
dc.identifier.citationDupuis J, Wang F, Nathan H, Lam M, Grimes S, Bourke M: The cardiac anesthesia risk evaluation (CARE) score: A clinically useful predictor of mortality and morbidity in cardiac surgery. Anesthesiology 2001;94:191-193
dc.identifier.citationIsaaz K.: What are we actually measuring by Doppler tissue imaging?. J. Am. Coll. Cardiol. 2000 Sep;36(3): 897-9.
dc.identifier.citationLiel-Cohen N, Tsadok Y, Beeri R: A new tool automatic assessment of segmental wall motion base don longitudinal 2D strain: a multicenter study by the Israeli Echocardiography Research Group. Circ Cardiovasc Imaging 2010 Jan; 3 (1): 47-53.
dc.identifier.citationBaek HK, Park TH, Park JS, Seo JM, Park SY, Kim BG, Kim SO, Cha KS, Kim MH, Kim YD. Segmental tissue Doppler image-derived tei index in patients with regional wall motion abnormalities. Korean Circ J. 2010 Mar;40(3):114-8.
dc.identifier.urihttp://hdl.handle.net/10818/1376
dc.description60 Páginas.
dc.description.abstractEl tiempo de circulación extracorpórea para determinar complicaciones a nivel cardiovascular es controversial. El objetivo de este estudio es determinar si existe una asociación entre el tiempo de circulación extracorpórea y los nuevos trastornos de la contractilidad segmentaria en las primeras 24 horas de posoperatorio de cirugía cardiaca por medio de la realización de ecocardiograma preoperatorio y posoperatorio. Se realizó un estudio de cohorte con 183 pacientes que fueron llevados a todo tipo de cirugía cardiaca y se excluyeron 17 pacientes. Se encontró una incidencia de trastornos de contractilidad segmentaria de un 20%; no hubo asociación con el tiempo de circulación extracorpórea pero se encontró asociación con la cirugia de revascularización miocárdica menor de 3 vasos.es_CO
dc.language.isospaes_CO
dc.publisherUniversidad de La Sabana
dc.sourceUniversidad de La Sabana
dc.sourceIntellectum Repositorio Universidad de La Sabana
dc.subjectCuidados intensivoses_CO
dc.subjectCorazón-Cirugíaes_CO
dc.subjectAtención al enfermoes_CO
dc.subjectRevascularización del miocardioes_CO
dc.titleDescripción de la asociación del tiempo de circulación extracorpórea y trastornos en la contractilidad miocárdica.es_CO
dc.typebachelorThesis
dc.publisher.programEspecialización en Medicina Crítica y Cuidado Intensivo
dc.publisher.departmentFacultad de Medicina
dc.identifier.local142330
dc.identifier.localTE00042
dc.type.localTesis de especialización
dc.type.hasVersionpublishedVersion
dc.rights.accessRightsopenAccess
dc.creator.degreeEspecialista en Medicina Crítica y Cuidado Intensivo


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem